ff879893-f359-4c0f-a841-8018b601aa70 (Collection)

Project:

91b694c3-f4d7-4ddd-8278-16f94e15c1c5

Project (Entity type)

Dcc Asset:

251215 4dn c2m2 submission.zip

Processed File (Entity type)

Dcc:

4DN

DCC (Entity type)

Collection:

451687f0-8195-496d-aa37-fead86dba857

Subject (Entity type)

Persistent Id:https://data.4dnucleome.org/4DNESNXH2OHP

Description:4DNESNXH2OHP: TSA-seq SON in treated RPE1 cells - G1 phase and log growth - anti-SON - log phase - untreated Replicates of SON TSA-seq Reaction Condition E (PBS 50% Sucrose, 1:300 tyramide biotin) 30 minute reaction on untreated log phase RPE1 cells

Creation Time:2025-10-01T00:00:00

Abbreviation:4DNESNXH2OHP

Results found

Linked to

	Label	Description
	f3aae8f4-fc5f-4fbe-932e-fab0d8b6670a Collection (Entity type)	Biological replicate 1, Technical replicate 1 of 4DNESNXH2OHP
	451687f0-8195-496d-aa37-fead86dba857 Subject (Entity type)	A subject from 4DN produced as part of the 91b694c3 f4d7 4ddd 8278 16f94e15c1c5 project
	d385e52b-a007-478c-a297-da01dd2fbe21 Collection (Entity type)	Biological replicate 2, Technical replicate 1 of 4DNESNXH2OHP
	91b694c3-f4d7-4ddd-8278-16f94e15c1c5 Project (Entity type)	COMBINED CYTOLOGICAL, GENOMIC, AND FUNCTIONAL MAPPING OF NUCLEAR GENOME ORGANIZATION https://project...

f3aae8f4-fc5f-4fbe-932e-fab0d8b6670a

Collection (Entity type)

Biological replicate 1, Technical replicate 1 of 4DNESNXH2OHP

451687f0-8195-496d-aa37-fead86dba857

Subject (Entity type)

A subject from 4DN produced as part of the 91b694c3 f4d7 4ddd 8278 16f94e15c1c5 project

d385e52b-a007-478c-a297-da01dd2fbe21

Collection (Entity type)

Biological replicate 2, Technical replicate 1 of 4DNESNXH2OHP

91b694c3-f4d7-4ddd-8278-16f94e15c1c5

Project (Entity type)

COMBINED CYTOLOGICAL, GENOMIC, AND FUNCTIONAL MAPPING OF NUCLEAR GENOME ORGANIZATION https://project...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.